IDXX
IDEXX LABORATORIES INC /DE
IDEXX LABORATORIES INC /DE (IDXX) has 10 SEC Form 4 filings (73 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Mar 2, 2026.
Insiders have net sold $25.3M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Jonathan J. Mazelsky
- Employees:11,000
- HQ:Westbrook, ME, US
- IPO:1991-06-21
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$25.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$45.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
MAZELSKY JONATHAN JAYFirst filing | President and CEO | Sale | 23,326 | $15.3M | Mar 2 | SEC ↗ |
Erickson Michael GFirst filing | Executive Vice President | Sale | 5,371 | $3.4M | Feb 19 | SEC ↗ |
Hunt NimrataFirst filing | Executive Vice President | Sale | 9,425 | $6.6M | Nov 10 | SEC ↗ |
Congress trading IDXX
See timeline →- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
IDEXX LABORATORIES INC /DE is in the Healthcare sector.